PMC:7376974 / 5288-5682
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T10 | 83-88 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T11 | 218-222 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 51 | 332-344 | Chemical | denotes | nanovaccines |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T41 | 83-93 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells will |
| T42 | 162-170 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T43 | 218-222 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T44 | 239-249 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T25 | 124-133 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T10 | 162-191 | http://purl.obolibrary.org/obo/GO_1903902 | denotes | activity in viral replication |
| T11 | 174-191 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
| T12 | 174-191 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
| T13 | 239-268 | http://purl.obolibrary.org/obo/GO_0002253 | denotes | activation of immune response |
| T14 | 253-268 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T35 | 13-232 | Sentence | denotes | Subsequently, the interaction of HNMs after internalization into host cells will be addressed, stressing their antiviral delivery features and their activity in viral replication blockage, leading to host cell survival. |
| T36 | 233-374 | Sentence | denotes | Then, activation of immune response induced by HNMs, triggering the innate and the adaptive (e.g., nanovaccines) immunity, will be presented. |